Acquired chromosomal DNA amplifications are features of many tumors. Although overexpression and stabilization of the histone H3 lysine 9/36 (H3K9/36) tri-demethylase KDM4A generates transient site-specific copy number gains (TSSGs), additional mechanisms directly controlling site-specific DNA copy gains are not well defined. In this study, we uncover a collection of H3K4-modifying chromatin regulators that function with H3K9 and H3K36 regulators to orchestrate TSSGs. Specifically, the H3K4 tri-demethylase KDM5A and specific COMPASS/KMT2 H3K4 methyltransferases modulate different TSSG loci through H3K4 methylation states and KDM4A recruitment. Furthermore, a distinct chromatin modifier network, MLL1-KDM4B-KDM5B, controls copy number regulation at a specific genomic locus in a KDM4A-independent manner. These pathways comprise an epigenetic addressing system for defining site-specific DNA rereplication and amplifications.
INTRODUCTION
Cancer cells have multiple chromosomal aberrations. Genomewide studies of somatic copy number alterations (SCNAs) across multiple different tumor types have demonstrated that specific chromosomal regions exhibit higher frequencies of DNA copy number gains and amplifications, with a concomitant increase in the associated gene expression (Beroukhim et al., 2010; Kim et al., 2013; Zack et al., 2013) . These regions frequently harbor pro-survival genes and oncogenes. For example, the gain of chromosome 1q12-25 (chr 1q12-25) are associated with a number of drug resistance-associated oncogenes (e.g., MCL1, CKS1B; [Beroukhim et al., 2010; Diskin et al., 2009; Fonseca et al., 2006; Inoue et al., 2004; Kudoh et al., 1999; Petersen et al., 2000] ). Drug selection can also result in the appearance of integrated or extrachromosomal gene amplification as seen for dihydrofolate reductase (DHFR) when cells are treated with methotrexate (Alt et al., 1978; Biedler and Spengler, 1976a, 1976b; Haber and Schimke, 1981) or the loss of extrachromosomal fragments for epidermal growth factor receptor (EGFR) gene amplifications in glioblastoma patients (Nathanson et al., 2014) . A recent study illustrated that $50% of the evaluated tumors contain extrachromosomal amplifications that impact tumor heterogeneity and help in tumor adaptation (Turner et al., 2017) . Even though DNA copy gains are frequent in cancer, little knowledge exists about the mechanisms that generate sitespecific DNA copy gains de novo or under selective pressure.
Previously, overexpression and stabilization of histone 3 lysine 9/36 (H3K9/36) tri-demethylase KDM4A, as well as the direct modulation of chromatin states (i.e., H3K9 and K36 methylation), resulted in site-specific DNA copy gains of drug-resistance-associated loci without causing genome-wide chromosomal instability (i.e., chr 1q12h, 1q21.2, 1q21.3). These DNA copy gains were extrachromosomal, occurred during S phase, and were lost in late S/early G2 phase of the cell cycle (Black et al., 2013 (Black et al., , 2015 (Black et al., , 2016 . The transient behavior of the KDM4A-dependent DNA copy gains highlights the inherent plasticity that these epigenetic factors could confer to regions that undergo amplification. This discovery emphasized that a single chromatin factor modulated transient site-specific copy gains (TSSGs) (Mishra and Whetstine, 2016) . However, this initial study did not address whether additional chromatin factors or their associated histone methylation states control TSSG formation. Furthermore, it remained unclear how KDM4A is targeted or whether additional mechanisms control TSSG formation independent of KDM4A. Answering these outstanding questions will expand our understanding about the regulation and impact of site-specific copy gains and identify mechanisms contributing to pathological DNA amplifications.
This study begins to address how chromatin modulators and their associated histone modification states impact site-specific rereplication and DNA copy gains. By conducting an unbiased small interfering RNA (siRNA) screen for lysine demethylases (KDMs), a role for the H3K4 tri-demethylase KDM5A in restricting TSSGs was identified. KDM5A depletion and increased H3K4me3 serve as beacons for KDM4A recruitment and the associated amplifications. Furthermore, a cross-talk between specific MLL/COMPASS H3K4 methyltransferases, KDM5A and KDM4A at subsets of TSSGs was discovered. In addition, a KDM4A-independent TSSG site was uncovered. This TSSG was regulated by an intricate interplay between KMT2A/MLL1, KDM5B, and KDM4B. These findings highlight a key role for H3K4 methylation in regulating TSSGs while illustrating a more generalizable role for chromatin modifiers and localized epigenetic states in controlling rereplication and DNA amplification.
RESULTS

KDM5A Depletion Promotes Site-Specific Copy Gains
Our laboratory demonstrated that histone lysine demethylase KDM4A generated TSSGs of regions on chromosomes 1 and X (Black et al., 2013) . These loci have been linked to drug resistance and poor patient outcome (Fonseca et al., 2006; Inoue et al., 2004; Kudoh et al., 1999) . In fact, the chromosome 1q12h region has been observed as an enriched region across several tumor types upon KDM4A amplification (Black et al., 2013) . Using the TCGA pan-cancer dataset (7,885 samples) obtained from the TCGA GDAC (Zack et al., 2013) , we measured the percentage of samples carrying an amplification (R2.4 copies) in each of the loci on chromosome 1 associated with TSSGs. We also measured EGFR and MYC as representatives of frequently amplified cancer driver genes (Table S1 ). These data illustrate that amplification of these genomic regions occurs frequently in tumors (e.g., 21% for 1q21.3 compared to 26% for MYC in liver cancer), which raises the possibility that additional chromatin factors control their copy gains. Therefore, we conducted an unbiased siRNA screen against all lysine demethylase families (KDM1-KDM7) (Figure 1A) . These were performed in immortalized retinal pigment epithelial cells (RPEs) that have a nearly diploid genome (Black et al., 2013; Jiang et al., 1999) . Each independent set of siRNAs was validated and assessed for major cell cycle defects by flow cytometry analysis before being assayed by DNA fluorescence in situ hybridization (DNA FISH) (Figures S1A-S1Q).
Evaluation of FACS profiles revealed that several KDMs resulted in modest yet significant changes in cell cycle distribution (Figures S1K-S1Q). For all KDM siRNA samples, we initiated the TSSG screen with a FISH probe against a well-characterized locus (chromosome 1q12h; referred to as 1q12h) that has been used to elucidate TSSG events in cancer cells (Black et al., 2013 (Black et al., , 2015 (Black et al., , 2016 . We also included another probe that did not undergo TSSG across a panel of experimental conditions, serving as a negative control region (chromosome 8 centromere, 8c) ( Figures 1B, 1C , and S1R-S1W). Positive hits for 1q12h DNA copy gain were then screened against a panel of other TSSG sites and additional chromosome 1 regions that had not been observed to undergo copy gains by DNA FISH (e.g., 1q23.3 was used for all conditions throughout the paper; Table S2 ) (Black et al., 2013 (Black et al., , 2015 (Black et al., , 2016 . This approach ensures TSSG site-specificity versus global instability. For all FISH probes, we have plotted the data as percentages of copy gains per probe per cell instead of a ratio against a selected control region such as 1q23.3. This method allows one to see the specificity for copy changes while appreciating baseline copy number levels for regions being FISHed within and across chromosomes (Møller et al., 2018) and also ensures that we can detect copy number changes at centromeric regions that would be otherwise lost through normalization.
From our screen, only the depletion of KDM5A caused a significant increase in 1q12h copy gains, while 8c showed no significant changes ( Figures 1B, 1C , S1I, and S1O). The 1q12h copy gains were further validated with cells depleted with independent shRNAs targeting KDM5A (Figures S1X and S1Y). Furthermore, spectral karyotyping (SKY) of KDM5A depleted cells showed no major karyotype issues (data not shown). These results were not cell type dependent, as H2591 lung cancer cells also exhibited 1q12h copy gain upon KDM5A depletion (Figure 1D and Figures S1Z-S1A'). KDM5A depletion was also sufficient to cause other previously identified TSSGs to undergo copy number gains (i.e., 1q21.2 and Xq13.1), while additional regions on chromosome 1 and X (i.e., 1q23.3, 1qTel, Xcen) remained unaffected (Figure 1E and Table S2 ).
To further assess the role of KDM5A depletion, we applied chemical inhibition to assess TSSG formation (KDM5i, KDM5-C70 [Johansson et al., 2016] ) (Figures 1F-1G and S1B'-S1D'). KDM5i treatment caused a global increase in H3K4me3 level, as observed previously (Figure S1C') . Furthermore, KDM5i caused a dose-dependent increase in 1q12h copy gains in multiple cell lines ( Figures 1F, 1G , S1B', and S1D'). Consistent with the requirement for KDM5A in regulating TSSGs, chromatin immunoprecipitation (ChIP) analyses demonstrated a significant reduction of KDM5A at TSSG sites upon KDM5A siRNA treatment ( Figure 1H ), which suggests that KDM5A directly binds to these regions to suppress copy number gains.
KDM5A-Dependent Copy Gains Are Transient, Require S Phase, and Are Derived from Rereplication TSSGs are transient and occur in an S-phase-dependent manner (Black et al., 2013) . To determine whether KDM5A-dependent gains were transient, we washed off KDM5i and assessed TSSGs (Figure 2A ). RPE cells generated copy gains after 48 or 72 hr of KDM5i treatment (no wash off); however, DNA copy gains were significantly diminished after the drug was removed (24 hr wash off, Figures 2B, 2C , and S2A). Consistent with these observations, extra copies were not observed on mitotic chromosomes after KDM5i treatment (i.e., 1q12h; Figure S2B) . These experiments highlight the transient nature of the KDM5A-dependent copy gains.
In order to determine whether the copy gains are generated during S phase, RPE cells were arrested in G1/S with hydroxyurea (HU) treatment before receiving KDM5i ( Figure 2D ). The pretreatment with HU blocked KDM5i from generating DNA copy gains ( Figures 2E and S2C ). However, KDM5i-treated cells released from HU generated copy gains ( Figures 2F and S2C ), demonstrating that KDM5i results in S-phase-dependent copy gains.
Rereplication is one mechanism underlying TSSG generation (Black et al., 2013) . In order to determine whether depletion of KDM5A induced rereplication, we first performed cesium chloride density gradient ultracentrifugation to isolate rereplicated DNA (termed heavy-heavy, H:H; Figures 2G and S2D) for both control and KDM5A knockdown cells. The heavy-heavy fractions for each cellular condition were pooled together before the genomic DNA was purified and quantified by polymerase chain reaction (qPCR) (Figure 2G) . We observed significant enrichment of heavy-heavy DNA at copy gained regions 1q12h, 1q12/21, 1q21.2, and Xq13.1 upon KDM5A depletion ( Figure 2H) ; however, no enrichment was observed at the 1q23.3 control region. This suggested that reduced KDM5A levels promote rereplication at sites undergoing TSSG.
KDM5A Depletion Promotes TSSG Generation Post S Phase
TSSGs generated by KDM4A overexpression are cleared by the end of S phase and beginning of G2 phase of the cell cycle (Black et al., 2013 ). Therefore, we tested whether the copy gains generated by KDM5A depletion follow the same kinetics. The cells were arrested in late G2 with a CDK1 inhibitor (CDK1i, Ro-3306) before copy gain was analyzed by DNA FISH ( Figure 2I ). We observed that the TSSGs generated by KDM5A depletion occurred after Ro-3306 treatment (Figures 2J, S2E, and S2F) , which demonstrated that copy gains occurred or persisted outside of S phase. Therefore, either the mechanism(s) that remove copy number gains are altered in KDM5A depleted cells, or the copy gains are still being generated during the G2 phase of the cell cycle in KDM5A depleted cells. Since these copy gains were transient, we hypothesized that KDM5A depletion created a permissive chromatin state that allowed replication to occur during late G2. To test this possibility, we determined whether DNA polymerase (i.e., DNA Pola) was present during late G2 at rereplicated regions. Upon KDM5A depletion, cells arrested in late G2 had enriched DNA Pola occupancy at rereplicated and copy-gained loci compared to control cells, while a non-copygained locus did not have DNA Pola enrichment ( Figure 2K ). Furthermore, we observed significant enrichment of EdU in late G2 upon KDM5A depletion, which suggested that DNA synthesis occurred during late G2 arrest (Figures 2L, S2G, and S2H) . Taken together, our observations support the hypothesis that KDM5A depletion alters the chromatin state so that rereplication and copy gains occur during S phase and continues into late G2, which is consistent with a previous report suggesting that KDM5A impacts origin recognition (Huang et al., 2016) .
KDM5A-Dependent Copy Gains Require KDM4A KDM5A demethylates H3K4me3/2/1 and associates with reduced gene expression (Christensen et al., 2007; Iwase et al., 2007; Klose et al., 2007) . Therefore, KDM5A depletion could promote KDM4A overexpression and, in turn, cause TSSGs as previously shown (Black et al., 2013) . However, KDM4A protein levels did not change upon KDM5A depletion ( Figure S3A ). Since the Tudor domains within KDM4A recognize H3K4me3 and H4K20me3 (Huang et al., 2006; Spektor and Rice, 2009) and are required for TSSGs (Black et al., 2013) , we hypothesized that KDM5A depletion promotes DNA copy gains by increasing H3K4me3 and enriching KDM4A at rereplicated and DNA copy-gained sites. In fact, there were increased levels of H3K4me3 (Figures 3A and S3B) and KDM4A occupancy (Figure 3B) at regions undergoing amplification upon KDM5A depletion, but not within the non-copy-gained loci (1q23.3) . Therefore, we conducted DNA FISH on cells co-depleted for KDM4A and KDM5A or depleted for KDM4A and then treated with KDM5i ( Figures S3C and S3D ). Depletion of KDM4A blocked the DNA copy gains observed with either KDM5A depletion or KDM5i treatment ( Figures 3C and 3D ). In addition, the introduction of a histone H3.3 lysine 4 mutant (H3K4M) abrogated the TSSG generated by KDM5A depletion and KDM4A overexpression ( Figures 3E-3F , S3E, and S3F). These observations illustrate a mechanism for recruiting KDM4A to sites that undergo site-specific rereplication and copy gains.
H3K4 KMTs Regulate Specific Sites Undergoing TSSG
Our results emphasized the importance of H3K4 methylation balance in regulating TSSGs. Therefore, we tested whether the H3K4 lysine methyltransferases (KMTs) regulate site-specific copy gains. Six H3K4 KMTs are part of the COMPASS family (MLL1/KMT2A, MLL2/KMT2B, MLL3/KMT2C, MLL4/KMT2D, SETD1A, and SETD1B; [Shilatifard, 2012] ). Emerging evidence suggests that they have both overlapping and unique functions in the genome through their roles in controlling K4 methylation states (Hu et al., 2013 (Hu et al., , 2017 Lee et al., 2013; Shilatifard, 2012) .
First, KDM5A and KMT2 co-depletion experiments were conducted to identify the enzyme(s) balancing KDM5A modulation at TSSGs. The KMTs that rescued the TSSGs generated by KDM5A depletion were then assessed for their ability to generate TSSGs upon overexpression alone. By requiring the KMT to score in both assays, there was an increased probability that the enzyme was directly involved in modulating site-specific copy gains ( Figure 4A ).
The individual depletions and co-depletions for each KMT siRNA were verified for knockdown and assessed for major alterations in cell-cycle profiles by FACS (Figures S4A-S4M ). Only minor, yet significant cell-cycle arrests were observed with KMT siRNAs. For example, SETD1A depletion alone resulted in an increase in G1/S, as previously reported ( Figure S4L ) (Tajima et al., 2015) . We then evaluated copy gains upon the depletion of individual KMTs ( Figures S4N-S4V ). Only SETD1A depletion appeared to cause copy gains at most sites tested ( Figure S4O , S4R, and S4U), which likely suggests global chromosomal instability in SETD1A-depleted cells. These data were consistent with SETD1A having key roles in modulating genome stability during cell division and by modulating DNA damage pathways (Hoshii et al., 2018; Tajima et al., 2015) .
While independent KMT depletions did not cause site-specific gains, the depletion of select KMTs altered copy gains caused by KDM5A knockdown (Figures S4N-S4V ). For example, depletion of KMT2B, KMT2C, KMT2D, and SETD1B rescued 1q12h and 1q21.2 copy gains caused by KDM5A depletion (Figures S4N-S4S ). On the other hand, KMT2A/MLL1 and KMT2D/MLL4 depletion rescued 1q21.3 DNA copy gains ( Figure S4T ). These data suggest a higher degree of specificity for KMTs in generating site-specific DNA copy gains in the genome compared to KDMs. Since KMTs control the degree of methylation at specific locations in the genome (Hu et al., 2013 (Hu et al., , 2017 Lee et al., 2013; Shilatifard, 2012) , the cross-talk between H3K4 KMTs (e.g., monomethyltransferases and trimethyltransferases) likely control the final methylation state and, in turn, the impact on TSSG formation. Therefore, the H3K4 methylation interplay between KMTs could explain why a collection of KMTs impacts certain TSSGs (e.g., 1q12h and 1q21.2).
To ensure that each KMT was truly regulating the sites undergoing TSSG, we overexpressed individual H3K4 KMTs except KMT2C because we could not generate a full-length expression vector. Overexpression was validated, and cells were FACS profiled ( Figures S4W-S4B' ). Upon overexpression, an even higher degree of specificity was observed for the KMTs than for the KDMs ( Figures 4A and S4C'-S4N' ). For example, SETD1B was the only KMT that generated 1q12h copy gains upon overexpression ( Figures 4A and S4C' ). The other KMTs did not generate 1q12h copy gains ( Figures S4D'-S4F' ) even though some of them rescued the copy gains observed in KDM5A-depleted cells ( Figures S4N-S4P ). Consistent with the requirement for SETD1B catalytic activity to generate 1q12h, MDA-MB-231 breast cancer cells that had the SETD1B methyltransferase domain deleted (DSET domain [Wang et al., 2017] ) were unable to generate 1q12h TSSGs upon KDM5A depletion ( Figures S4O'-S4P' ). In the case of 1q21.2, DNA copy gains were caused by KMT2B, KMT2D, and SETD1B ( Figure S4G '-S4I'), while only KMT2A and KMT2D overexpression caused 1q21.3 DNA copy gains . These observations illustrate that specific subsets of H3K4 KMTs are maintaining a balance with KDM5A at sites undergoing TSSG ( Figure 4A ).
Since KMT2 family members balance the TSSGs generated by KDM5A depletion and KDM4A was required for KDM5A-associated copy gains, we hypothesized that individual KMTs generate their associated TSSG via KDM4A. To test this hypothesis, we depleted KDM4A before overexpressing individual H3K4 KMTs ( Figures 4B-4I and S5A-S5G). Since KMT2B expression was decreased after KDM4A depletion ( Figure S5C ), we did not assess the copy-gain relationship for this pair. However, TSSGs generated by overexpression of the other H3K4 KMTs were either completely or partially rescued upon KDM4A depletion ( Figures 4B-4I ). For example, depletion of KDM4A suppressed SETD1B generated 1q12h and 1q21.2 gains (Figures 4B-4C and 4E-4F) but only partially rescued 1q21.2 copy gains generated by KMT2D overexpression ( Figure 4D ). The 1q21.3 TSSG generated by either KMT2A or KMT2D overexpression was rescued upon KDM4A depletion ( Figures 4G-4I ). These data emphasize the need to balance KMT/KDM expression so that site-specific DNA amplification is kept in check.
Identification of a KDM4A-Independent TSSG While testing whether KDM4A depletion could suppress each KMT-driven copy gain, we observed that KMT2A overexpression resulted in DNA copy gains at 1p32.3 ( Figure 4G ). This region did not copy gain with either KDM4A overexpression or KDM5A depletion ( Figures 5A and 5B) . Therefore, KMT2A overexpression generated a site-specific copy gain through another set of chromatin regulators.
We tested whether KDMs related to H3K4 could balance KMT2A-dependent DNA copy gains at 1p32.3. An siRNA screen against KDM5 family members identified KDM5B as a significant regulator of 1p32.3 DNA copy gains ( Figures 5A and 5B ). Consistent with this observation, shRNAs targeting independent sites within KDM5B also generated 1p32.3 copy gains ( Figure S5H ). Furthermore, chemical inhibition of the KDM5 family members generated copy gains of both 1p32.3 and 1q21.3 regions (Figure 5C ). In order to determine if the 1p32.3 copy gains are transient, the KDM5i drug was washed off and the copy gains returned to baseline levels ( Figures 5D and 5E) . We did not observe extra 1p32.3 or 1p21.3 copies on metaphase spreads generated from KDM5i treated cells ( Figure S5I ). Collectively, these data suggest that the 1p32.3 copy gains are transiently generated.
We then demonstrated that KDM5B overexpression could block KMT2A-generated 1p32.3 copy gains (Figures 5F and S5J) without interfering with the other KMT2A copy-gained site (1q21.3) under KDM5A regulation ( Figure 5F ). The introduction of H3K4M also abrogated KDM5B-and KMT2A-dependent 1p32.3 copy gains (Figures 5G-5H, S3E, and S5K-S5M). In fact, H3K4M blocked both of the copy-gained regions generated by KMT2A (1p32.3 and 1q21.3) even though specific KDM5 members controlled these TSSGs. These data underscore an important role for H3K4 KMTs and KDMs in regulating TSSGs at other genomic loci that are independent of KDM4A regulation.
1p32.3 DNA Copy Gains Require KDM4B Besides KDM4A, KDM4B and KDM4C also have Tudor domains that are involved in their recruitment to chromatin (Pedersen et al., 2016; Su et al., 2016). Therefore, we hypothesized that additional KDM4 enzymes could be involved in regulating 1p32.3 DNA copy gains. To test this hypothesis, we overexpressed KDM4A-C family members and assessed whether copy gains occurred at 1p32.3 locus. Only catalytically active Consistent with KDM4B overexpression causing rereplication and copy gains, mass spectrometry analyses identified an association of KDM4B with replication machinery proteins (i.e., MCM3, MCM5, MCM7, RFC3, and DNAJA3) that was verified by co-immunoprecipitation analyses (Figures S6G and S6H  and Table S4 ). These interactions were also confirmed in vivo by using NanoBRET (short for nano-luciferase bioluminescent resonance energy transfer), a proximity based protein:protein interaction live-cell assay. Consistent with our previous discovery (Black et al., 2013) , KDM4A interacted with the MCM proteins and DNA polymerases (Figure 6E, top panel) . In addition, energy transfer between KDM4B and the MCMs and DNA polymerase subunits were observed to varying degrees across multiple subunits within these larger complexes, which indicates association of KDM4B with these protein complexes (Figure 6E , bottom panel and Figure S6I ). Taken together, these results suggest that KDM4B directly associates with replication machinery to promote rereplication and copy gain of the 1p32.3 region.
Since KMT2A promoted 1p32.3 DNA copy gain in a KDM4A-independent manner ( Figure 4G ), we tested whether KDM4B was required for KMT2A-generated copy gains of 1p32.3. KDM4B depletion abrogated KMT2A-generated 1p32.3 copy gains, demonstrating that KDM4B was essential for the copy gain generation by KMT2A ( Figures 7A, S7A , and S7B). KDM4B was also required for the copy gain generated with KDM5B depletion, while KDM4A depletion did not have any effect on 1p32.3 copy gains . Consistent with this observation, 1p32.3 generated with KDM5i treatment was also blocked with KDM4B depletion (Figures 7C and S7H) . Furthermore, the introduction of the H3K4M mutant abrogated the 1p32.3 copy gain generated by KDM4B overexpression ( Figures 7D, S3F , S7I, and S7J), which suggests that KDM4B recruitment on chromatin occurs via H3K4 methylation. Consistent with this possibility, the NanoBRET assay demonstrated that cells expressing H3K4M had reduced KDM4B associated with chromatin in vivo (Figures 7E and 7F) .
Our data suggest that KDM4B recruitment is required for the rereplication and 1p32.3 copy gains. By ChIP, KDM4B enrichment was observed at the rereplication sites upon stable overexpression ( Figure 7G ). Furthermore, siRNA depletion of KDM4B in KDM4B-overexpressing cells reduced the occupancy of KDM4B to the baseline level at the rereplicated regions (1p32.3-4 and 1p32.3-5, Figures S7K and S7L ). Since KDM4B catalyzes demethylation of histone lysine 9 and lysine 36 residues, we tested whether direct methylation interference by introducing H3K9M and H3K36M histone mutations would induce 1p32.3 copy gains (Black et al., 2013) . Introduction of both K9M and K36M caused copy gains of the 1q12h, 1q21.2, and 1q21.3 regions , which was consistent with our previous report (Black et al., 2013 (Black et al., , 2015 . However, only H3K36M caused the 1p32.3 locus to undergo copy gains, while a non-copy-gained region 1q23.3 remained unchanged ( Figures 7H and S7Q ), suggesting specificity for H3K36 methylation in causing 1p32.3 copy gains.
Since KDM4B is recruited to the rereplicated and copy-gained region and the copy gains are catalytically dependent, we assessed the impact of KDM4B overexpression on H3K36me3 (legend continued on next page) at 1p32.3 locus. A significant decrease in the H3K36me3 levels occurred with KDM4B overexpression at the rereplicated region (i.e., 1p32.3-3, À4 and À5), while a non-rereplicated region (1p32.3-6) remained unaffected ( Figures 7I and S7R) . Taken together, these data suggest that KDM4B recruitment and catalytic activity is essential for reducing H3K36me3 at the rereplicated and copy-gained 1p32.3 locus ( Figure 7J ). These results highlight the importance of localized chromatin states and appropriate KMT-KDM balance in preserving DNA copy number within the genome ( Figure 7K ).
DISCUSSION
We have identified a compendium of epigenetic factors, specifically lysine methyltransferases and demethylases, that directly impact locus-specific DNA copy gains ( Figure 7K ). These chromatin modulators control histone lysine 4 methylation state and, in turn, coordinate specific H3K9 and K36 tri-demethylases to regulate rereplication and DNA copy gains of specific genomic loci. Our results uncover a mechanism for achieving site-specific copy gains through the cross-talk of eight chromatin regulators and their modulation of localized chromatin states. These studies have broad implications in understanding how genomes undergo amplification during development, stress conditions, and disease states.
H3K4 Methylation and TSSGs
Chromatin and chromosomal architecture play an important role in DNA replication and, in turn, genome stability (Dileep et al., 2015; MacAlpine and Almouzni, 2013; Smith and Aladjem, 2014) . For example, H3K4 methylation has been suggested to promote rereplication (Huang et al., 2016; Lu et al., 2016b) . Specifically, WDR5 depletion, which blocks most COMPASS family of H3K4 KMTs, reduced the rereplication and the polyploidy phenotype observed when replication licensing was disrupted (Lu et al., 2016b) . Consistent with this observation, histone lysine 4 demethylases regulate DNA replication. For instance, KDM5C/ JARID1C regulated the pre-initiation complex assembly and proper firing of the early replication origins (Rondinelli et al., 2015) , while KDM5A regulated ORC recruitment to origin sites and thus proper regulation of replication (Huang et al., 2016) .
Our results suggest that COMPASS H3K4 KMT enzymes and the H3K4 tri-demethylases are controlling rereplication and DNA copy gains at specific loci. The balance between H3K4 KMTs and KDMs ''toggle'' H3K4 methylation at specific loci, which then regulates their ability to rereplicate and copy gain. Consistent with this hypothesis, each KDM5 H3K4 tri-demethylase controls a distinct subset of TSSG sites. Specifically, KDM5A controlled 1q12h, 1q21.2, and 1q21.3, while KDM5B regulated 1p32.3 ( Figure 7K ). In fact, KDM5i allowed all the observed TSSGs to emerge. Similarly, each COMPASS-family H3K4 methyltransferase regulated distinct genomic sites within the subset of known TSSGs being generated ( Figure 7K ). However, interference with H3K4 methylation by introducing H3K4M was able to suppress all the observed TSSGs. The H3K4M and KDM5i experiments emphasize that H3K4 methylation is a critical determinant of rereplication and that there is an exquisite specificity in KMTs-KDMs in controlling site-specific amplifications. These data suggest an epigenetic addressing system for controlling site-specific amplifications and underscore the importance of regulating the local chromatin states so that DNA amplifications are prevented or allowed to occur.
KMT-KDM Cross-Talk Generates TSSGs KDM4A-dependent TSSGs required the Tudor domains (Black et al., 2013) . These domains recognized H4K20me2/3 and H3K4me3 (Huang et al., 2006; Mallette et al., 2012; Spektor and Rice, 2009 ). However, the significance of either set of modifications in modulating KDM4A-driven biology remained an unanswered question. In this study, H3K4 methylation was critical for the KDM4A-dependent regulation of site-specific rereplication and DNA copy gains. For example, KDM5A depletion resulted in rereplication and TSSG formation for specific genomic loci that were dependent on increased H3K4 methylation and KDM4A recruitment. Furthermore, SETD1B, KMT2A, KMT2B, and KMT2D modulated subsets of loci that undergo copy gains upon KDM5A depletion and KDM4A overexpression. Therefore, we propose that increased H3K4me3 helps hone KDM4A recruitment through its Tudor domain and promotes more permissive chromatin for DNA rereplication.
We have also identified a non-KDM4A-dependent copy number regulation of chromosome 1p32.3 locus by a network of KDM5B-KDM4B-KMT2A histone modifying proteins. KDM4B also required H3K4 methylation to generate the 1p32.3 TSSG. KMT2A was necessary for KDM4B copy gains, while KDM5B prevented them. Furthermore, disruption of H3K4 methylation caused less KDM4B on the chromatin, illustrating the importance of this modification in recruiting another KDM4 member and, in turn, site-specific rereplication and DNA amplification. Our results suggest the existence of a complex molecular network of KMTs and KDMs that regulate site-specific copy gains and emphasize the importance of the KDM4 members in generating TSSGs. Therefore, chemical (Black et al., 2015) or RNA-based strategies (Black et al., 2016) targeting the KDM4 family could have a profound effect on DNA copy number heterogeneity in diseases such as cancer. Future studies need to identify other genomic and epigenomic features that are important for targeting the KMTs and KDMs to their associated TSSGs. Additional features (e.g., insulator elements, enhancers, CpG islands, and other DNA and histone modifications) likely function in concert with H3K4me3 to facilitate the recruitment of KMTs and KDMs to maintain DNA copy number control. Since (G) KDM4B ChIP from control and GFP-KDM4B stably overexpressing cells. The positions are noted in Figure 6D . (H) DNA FISH in cells transduced with H3.3K9M and -K36M. (I) A graph containing the H3K36me3/H3 ratio for control and GFP-KDM4B cells at the indicated genomic regions (see Figure 6D ). (J) A model depicting the interplay among KDM5B-KDM4B-KMT2A at 1p32.3 is shown.
(K) A model summarizing the KMT-KDM cross-talk at multiple chromosome 1 loci. The locations are based on genome assembly GRCh37-hg19. Error bars represent the SEM. *p < 0.05 by two-tailed Student's t test.
H3K4 methylation was required for the TSSGs, active transcription or select RNAs could also be important in TSSG formation. For example, the mis-expression of the HSATII repeat RNA promoted expansions in pericentromeric regions (Bersani et al., 2015) . Furthermore, extrachromosomal circular DNA elements were observed in gene-rich chromosomal regions (Møller et al., 2018) , which suggests a relationship between extrachromosomal generation and actively marked regions. Therefore, the relationship between RNA mis-expression and TSSG formation needs further evaluation.
Our studies illustrate the importance of systematically targeting the KDM families in order to either promote or block DNA copy gains (Figures 3, 4, and 7) . The ability to therapeutically control DNA amplifications could have profound implications in the areas of tumor heterogeneity and drug responses. Consistent with this possibility, KDM5 inhibition resulted in TSSGs and a reduced response to low dose cisplatin exposure across multiple cancer cell types . Future studies need to explore these preliminary observations and establish the role of specific TSSGs in drug responses. For example, does the reduced drug response that parallels DNA copy gains result from the general mechanism of TSSG formation (e.g., increasing the baseline of DNA copies) and/or result from the increased copies and expression of the associated drug-resistant oncogenes (e.g., CKS1B within 1q21.3)?
KDM4A amplified TSSGs were generated in the presence of both H3K9M and H3K36M; however, the KDM4B-copy-gained locus was specific to H3K36M. It is possible that the amplifications of specific regions are distinctly controlled by K36 and/or K9 methylation states. H3K36M is a known ''onco-histone'' associated with certain tumor types (Fang et al., 2016; Kallappagoudar et al., 2015; Lu et al., 2016a; Papillon-Cavanagh et al., 2017; Behjati et al., 2013) . Delineating how this onco-histone contributes to the tumor pathogenesis, especially from the perspective of maintaining replication fidelity and genome integrity, would be of paramount importance. Identifying the epigenetic landscape that underlies the onco-histone associated amplifications from our study in the relevant tumor models can shed light into the biology and tumorigenic mechanisms.
Future studies should also interrogate how mutations and genomic alterations within the KMT-KDM network can modulate DNA amplifications in the genome. For example, do known mutations or rearrangements in COMPASS family members alter the composition of DNA amplifications in the human genome (Lawrence et al., 2014; Lawrence et al., 2013; Van Rechem and Whetstine, 2014) ? Furthermore, we hypothesize that cellular cues and exposures could have an impact on mechanisms generating TSSGs. The extracellular environment and metabolic exposures have been implicated in promoting tumor heterogeneity (Almendro et al., 2013; Burrell et al., 2013; Meacham and Morrison, 2013) . A recent study demonstrated that signaling network analyses provided associations with DNA amplifications (Graham et al., 2017) . Consistent with this hypothesis, hypoxia generated TSSGs through KDM4A stabilization, which was blocked when cells were exposed to succinate, a natural metabolite that inhibits KDMs (Black et al., 2015; Smith et al., 2007) . Therefore, future studies should explore the impact that genetic variants and cellular exposures have on TSSG formation so that mechanisms promoting DNA copy amplifications can be resolved.
KDM5-Related TSSG Kinetics KDM5A depletion resulted in TSSGs that occur outside of S phase, which was consistent with a previous report suggesting that replication occurred inappropriately (Huang et al., 2016) . However, the appearance of these TSSGs is in sharp contrast to KDM4A overexpression alone (Black et al., 2013) . These data suggest that the H3K4 methylation state provides a permissive chromatin environment that allows recruitment and rereplication outside of S phase. KDM5A depletion would allow this modification to persist and promote KDM4A driven copy gains, whereas resetting the H3K4 methylation would block KDM4A recruitment upon KDM5A overexpression. Consistent with this model, KDM4A was recruited to enriched H3K4me3 sites at rereplicated regions. DNA polymerase alpha was enriched at copy-gained sites and EdU positive cells were increased in late G2 upon KDM5A depletion. Furthermore, H3K4M blocked the TSSGs generated by KDM4A overexpression and KDM5A depletion. These data highlight the importance of the localized chromatin environment in controlling site-specific rereplication and copy gains. However, we cannot rule out the possibility that KDM5A depletion also impacts an unknown mechanism(s) promoting copy gain removal.
Our study documents a repertoire of chromatin regulators that can generate transient DNA copy gains ( Figure 7K ). Given different cellular division rates within tissues and tumors, the differentially cycling cells could create significant heterogeneity as a consequence of rereplicated fragment generation. The expression, activity, and mutational status of the identified KMTs and KDMs could impact the spatial and temporal regulation of the rereplicated fragments. Therefore, cells that are actively dividing and have the appropriate genetic background will be able to execute these alterations, which could provide a basis for DNA copy number heterogeneity within a tissue and/ or tumor (Mishra and Whetstine, 2016) . Whether these fragments can be integrated and persist after G2 phase remain to be discovered. Nonetheless, these transiently generated copy gains could be generated in each cycle and then resolved by yet-undiscovered mechanisms. Future studies need to elucidate the pathways regulating the removal and regulation of TSSGs and whether these pathways work together with epigenetic dysregulation to control tumor heterogeneity and drug responses, which will ultimately identify novel diagnostic and therapeutic options.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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STAR+METHODS KEY RESOURCES TABLE
CONTACT FOR REAGENT AND RESOURCE SHARING
Requests for reagents and resources may be directed to the Lead Contact, Johnathan R. Whetstine (jwhetstine@hms.harvard.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS Cell Culture
The generation of stable cells, plasmids, antibodies and chemicals used can be found in the key resource table. Retinal pigment epithelial (RPE) and 293T cells were cultured in DMEM-high glucose (Sigma) media with 10% fetal bovine serum (FBS), 100U/ml penicillin, 100ug/ml streptomycin, and 2mM L-glutamine. H2591 lung cancer cells were cultured in RPMI (Sigma) with 10% fetal bovine serum, 100U/ml penicillin, 100ug/ml streptomycin, and 2mM L-glutamine. SK-N-AS cells were maintained in DMEM/F12 (GIBCO) with 10% fetal bovine serum (FBS), 100U/ml penicillin, 100ug/ml streptomycin, and 2mM L-glutamine. OVCAR5 cells were maintained in RPMI 1640 (Sigma) with 10% fetal bovine serum (FBS), 100U/ml penicillin, 100ug/ml streptomycin, and 2mM L-glutamine, glucose (0.25 g/L) and 1mM sodium pyruvate. MDA-MB-231 were cultured in DMEM-high glucose (Sigma) media with 10% fetal bovine serum (FBS), 100U/ml penicillin, 100ug/ml streptomycin, and 2mM L-glutamine. RPE, 293T, OVCAR5, MDA-MB-231, and SK-N-AS cells are female cells. H2951 cells are male.
METHOD DETAILS Plasmids, Constructs and BACs
The list of all the plasmids and constructs has been provided in the key resource table. The BAC clone, RP11-177A4, from CHORI BacPac was used to generate the FISH probes for Xq13.1. The information for this BAC is provided in key resource table and how the labeled probes were generated are in the DNA FISH section below.
Transfection Conditions siRNA transfections were performed using Lipofectamine 3000 transfection reagent (Invitrogen) in the OPTI-MEM medium (Life Technologies). Transfections were changed to complete media after 4 hr of transfection, and cells were collected 72 hr post transfection. Transient overexpression transfections were performed using Lipofectamine 3000 transfection reagent and P3000 reagent (Life Technologies) in OPTI-MEM medium for 4 hr, followed by change to complete media. Silencer select negative controls and siRNAs were purchased from Life Technologies. Their sequences and catalog numbers are in Table S5 . For co-transfection experiments, both the siRNA's were co-transfected at the same time and collected at 72 hr from transfection ( Figures 3C, Figures  S4A-S4V ). For siRNA/overexpression experiments, cells were transfected with siRNA's for 48 hr followed by 24 hr of plasmid overexpression ( Figures 4B, 4D -E, 4G-H and 7A) . For overexpression experiment in Figure 5F , cells were co-transfected with plasmids and collected 24 hr post expression. For Figures 7B and S7G , cells were first transfected with KDM4A/KDM4B siRNA's for 48 hr followed by another 48 hr of KDM5B siRNA transfections. At least two different siRNAs against every gene were used for every experiment. For overexpression studies, at least two independent plates were transfected.
shRNA Transfection or Transduction The shRNA clones for KDM5A and KDM5B were provided by the MPL core facility (MGH). Virus was generated by co-transfection of shRNA plasmids along with the packaging plasmids (psPAX2 and VSVG) in 293T cells. The virus containing supernatant was collected after 24 hr. RPE cells were infected in the presence of 8 mg/ml polybrene for 12 hr with the virus containing supernatant. Two clones for KDM5A shRNA (TRCN0000014629 and TRCN0000014632) were transiently transfected to generate virus and the viral supernatant was infected in RPE cells and collected 72 hr post infection. We were not able to generate stable cell lines with these KDM5A shRNAs in RPE cells. Data presented are the averages from two independently infected KDM5A shRNA clones. One clone of KDM5B shRNA (TRCN0000014762) were stably generated and used in this study. The stable cells with pLKO shEGFP control and KDM5B shRNA were seeded and collected 72 hr later for analysis. Data presented are the averages from two independent experiments containing duplicates of KDM5B stable shRNAs in each experiment. At least two biological replicates from FISH experiments were counted double blinded.
Transduction with Histone H3.3 variants Plasmids for H3.3 K4M, K9M and K36M mutants were provided by Peter Lewis (University of Wisconsin). Virus was generated by co-transfection of specific plasmids along with the packaging plasmids (AmphoPAK and VSVG) in 293T cells. The virus containing supernatant was collected after 24 hr. RPE cells were infected in the presence of 8 mg/ml polybrene for 12 hr with the viral supernatant (Black et al., 2013) . Cells were washed two times with DMEM. For H3.3K4M experiments, cells were infected for 24 hr followed by a total of 72 hr of siRNA transfections or another 24 hr with plasmid overexpression. For H3.3K9M and H3.3K36M, cells were collected 48 hr post infections for analysis by FISH and western blot. For every experiment, two independent virus preparations were used for transductions. Incorporation of the histone variants into chromatin was confirmed by cellular fractionation and western blotting for the FLAG tag in the chromatin fraction.
RNA extraction and quantitative real-time PCR Cells were washed and collected by trypsinization, followed by washing in PBS two times. Cell pellet was resuspended in Qiazol reagent (QIAGEN) and stored at À80 C before further processing. Total RNA was extracted using miRNAeasy Mini Kit (QIAGEN) with an on-column DNase digestion according to the manufacturer's instructions. RNA was quantified using NanoDrop 2000 (Thermo Scientific). Single strand cDNA was prepared using Super Script IV first strand synthesis kit (Invitrogen) using oligo dT primers or random hexamers. Expression levels were analyzed using FastStart Universal SYBR Green Master (ROX) [Roche] according to the manufacturer's instructions on a LightCycler 480 PCR machine (Roche). Samples were normalized to b-actin. Primer sequences are provided in Table S3 .
Western Blotting
Cells were trypsinized and washed two times with PBS before resuspending in RIPA lysis buffer [50mM Tris pH 7.4, 150mM NaCl, 0.25% Sodium Deoxycholate, 1% NP40, 1mM EDTA, 10% Glycerol] freshly supplemented with protease inhibitor and PhosSTOP phosphatase inhibitor cocktails (Roche). Cells were lysed on ice for 15 min and stored at À80 C until further processing. Lysates were sonicated for 15 min (30sec ON and 30sec OFF cycle) at 70% amplitude in QSonica Q700 sonicator (Qsonica) followed by centrifugation at 12,000rpm for 15min. Cell lysate was transferred to a fresh tube and protein estimations were performed with Pierce BCA reagent (Thermo Scientific). Equal amounts of proteins were separated by SDS gel electrophoresis and transferred on nitrocellulose membrane (BioTrace NT, Pall Life Sciences) at 4 C for at least 3 hr at a constant current. The membranes were blocked for at least 1 hr in 5% BSA-PBST (1X PBS with 0.5% Tween-20) or 5% milk-PBST and probed over night with specific antibodies as follows at the following dilutions: anti-KDM4A (NeuromAb, at 1:100 dilution, anti-KDM5A (ab70892, abcam) at 1:2000, anti-KDM4B (ab191434, abcam) at 1:2500, anti-H3 (ab1791) at 1:100,000, H3K4me3 (07-473, Millipore) at 1:5000, anti-GFP (73-131, NeuromAb) at 1:500, anti-FLAG HRP (A8592, Sigma) at 1:1000, anti-MCM2 (ab6153, abcam) at 1:1000, anti-MCM5 (ab6154, abcam) at 1:2000, anti-ßactin (MAB1501, Millipore) at 1:30,000, and anti-actinin (sc-17829, santacruz) at 1:2000. Membranes were washed three times in PBST the next day, incubated with goat anti-mouse IgG peroxidase conjugated secondary antibody (170-6516, Biorad) or goat anti-rabbit peroxidase conjugated secondary antibody (A00167, GenScript) at 1:2500 in 5% milk-PBST for at least 1hr at room temperature, washed 3 times with PBST and incubated in Lumi-Light western blotting substrate (12015200001, Roche) or SuperSignal West Pico PLUS Chemiluminiscent substrate (34577, ThermoScientific) for 1min. Membranes were developed with Lumi-Film Chemiluminiscent detection film (11666657001, Roche). Blocking for anti-FLAG HRP antibody was done overnight in 5%BSA-PBST before being incubated with HRP-conjugated anti-FLAG antibody, washed three times with PBST before being developed with chemiluminiscent substrate. The western blot images shown in the figures have been cropped and auto contrasted.
Cell Cycle Analyses
Asynchronous and synchronized cells were fixed and processed as performed in (Black et al., 2010) . Cells were stained with 10mM EdU (Sigma) for 1 hr prior to cell cycle analyses with EdU staining. Samples were washed with PBS, centrifuged at 1400rpm for 5 min, and permeabilized with 500mL PBS containing 0.5% Triton X-100 for 30 min. Cells were washed with PBS and centrifuged at 1400rpm for 5 min. Samples were stained with 1:100 dilutions of 1mg/mL PI solution and 0.5M EDTA with 100 mg RNase A. For EdU staining, samples were stained with 125mL of EdU mixture made in 1X PBS containing 2.5mL of CuSO 4 , 0.625mL of Alexa 647-Azide fluor and 1X reaction buffer additive present in Click-IT EdU flow cytometry kit (Life Technologies) for 1hr in dark. After EdU incubation, cells were washed once with PBS by centrifugation at 1400rpm for 5 min, followed by staining with PI solution for at least 1 hr at room temperature. Cell cycle distribution was analyzed by flow cytometer using an LSRII or Fortessa.
DNA Fluorescence In Situ Hybridization (FISH)
All FISH probes and associated commercial sources are noted in the key resource table. FISH probes for chromosome 1 classical satellite (1q12h), chromosome 8 centromere (alpha satellite; 8c), CDKN2C/CKS1B (referred to as 1p32.3 and 1q21.3) and chromosome X alpha satellite (Xcen) were purchased from Cytocell (Oxford Gene Technologies). Probes for 1q21.2, 1p32.3 and 1q23.3 were purchased from Agilent Technologies. The 1p32.3 (CDKN2C) probe shown alone in Figures (5E, 5G, 7C , 7D, 7H and S5H) was performed with a FISH probe purchased from Agilent Technologies (G101227R). The FISH protocol was performed as described previously in Black et al. (2013) . Briefly, cell suspensions were fixed in cold methanol:glacial acetic acid (3:1) solution before being spun onto 8 Chamber Polystyrene vessel tissue culture treated glass slides (Falcon, Fisher Scientific). The slides were air-dried and incubated in 2X SSC buffer for 2 min, followed by serial ethanol dilution (70%, 85% and 100%) incubations for 2 min each, for a total of 6 min. Air-dried slides were hybridized with probes that were diluted in appropriate buffer overnight at 37 C. The slides were washed the next day in appropriate wash buffers at 69 C with 0.4X SSC for Cytocell probes or commercially available Agilent wash buffer 1 followed by washing in 2X SSC with 0.05% Tween-20 (Cytocell probes) or commercially available Agilent wash buffer 2 (Agilent probes). The slides were incubated in 1mg/mL DAPI solution made in 1% BSA-PBS, followed by a final 1X PBS wash. After the wash, the slides were mounted with ProLong Gold antifade reagent (Invitrogen).
The BAC for Xq13.1 was prepared utilizing PureLink HiPure Plasmid Filter Maxiprep kit (Life Technologies) using the recommended modified wash buffer. Probes were nick translated (Abbot Molecular Kit) in the presence of fluorescently labeled dTTP (Enzo Life Science).
FISH images were acquired using an Olympus IX81 or Olympus IX83 spinning disk microscope at 40X magnification and analyzed using Slidebook 5.0 and Slidebook 6.0 softwares. A minimum of 20 z-planes with 0.5mm step size was acquired for each field. Copy number gains for 1p32.3, 1q12h, 1q21.2, 1q21.3, 1q23.3, 1qTel, 8c, Xq13.1 and Xcen were scored in RPE cells as three or more foci. For SK-N-AS cells, 1q12h copy gain was scored for any cell with 5 or more foci, 1p32.3 copy gain was scored for any cell with 3 or more foci and 1q21.3 as 4 or more foci. For H2591, 1q12h copy gain was scored for any cell with 6 or more foci. For MDA-MB-231, 1p32.3 copy gain was scored for any cell with 5 or more foci and 1q21.3 as 7 or more foci. For MDA-MB-231 with wild-type and SET domain deletion cells, 1q12h copy gain was scored for any cell with 6 or more foci and 8c as 5 or more foci. For OVCAR5, 1p32.3 copy gain was scored for any cell with 3 or more foci and 1q21.3 as 4 or more foci. At least 100 cells were counted for each replicate of each experiment. All FISH experiments include at least two biological replicates. Representative images that are shown in the figures have been auto contrasted. Images shown in Figure 1B were acquired with the Olympus IX81 spinning disk microscope and images shown in Figures 5 and 6 were acquired with the Olympus IX83 microscope system. Extended list of probes used are provided in the key resource table.
Since we observe copy gains in a centromere-related region (i.e., 1q12h) and because centromere regions are often used as a normalizer, we decided to present the FISH results as percentage of cells with copy gains per probe instead of a ratio against a selected control region. This approach allows one to see the specificity for copy changes at each locus, while appreciating the baseline levels for regions being FISHed within and across chromosomes. Recent reports highlight the need to consider that regions in the genome of somatic and cancer cells can have different baselines and that may not be a reflection of FISH noise but a biological property of the regions (Black et al., 2015; Møller et al., 2018; Turner et al., 2017) . The first experiment conducted with the probes included in the manuscript under a genetic or chemical evaluation are shown in Table S2 .
Metaphase Spreads RPE cells were seeded and treated with DMSO or KDM5-C70 inhibitor at 10uM concentration and collected after 72 hr. The cells were treated with KaryoMAX colcemid solution (GIBCO) at a final concentration of 2mg/mL for 4 hr. The cells were collected by mitotic shake off and washed with 1X PBS followed by swelling in 0.59% KCl (w/v) hypotonic solution for 1 hr 30 min. The reaction was stopped by addition of 3:1 solution of cold methanol:acetic acid, followed by 4 washes in this same fixative. The cells were then resuspended in 100ml of fixative solution. The cells were dropped on a glass slide from a height of 12-15 inches to make the metaphase spread. FISH was performed for the indicated probes post drying of the slides. The images were taken with 30 z-planes with 0.5 mm step size using the Olympus IX83 microscope. The images were analyzed for FISH using Slidebook 6.0 software.
EdU Immunofluorescence Staining
EdU staining was performed using the Click-iT EdU Alexa Fluor 488 Imaging Kit (Life Technologies) following manufacturer's protocol with minor modifications. In brief, RPE cells were plated on coverslips in 6-well plates (30,000 cells per well) and grown using standard tissue culture conditions. The cells were then transfected with two independent control and KDM5A siRNAs using Lipofectamine 3000 transfection reagent (Invitrogen) in OPTI-MEM medium (Life Technologies). The medium was changed to complete medium (DMEM) 4 hr after transfection. 52 hr after transfection, the cells were treated with a CDK1/cyclin inhibitor (Ro-3306) with a final concentration of 10 mM for 20 hr to be synchronized to late G2 phase. The cells were then labeled with EdU for a final concentration of 10 mM for 10 min before fixation with 3.7% formaldehyde in 1X PBS. The permeabilization and EdU detection steps were performed exactly as described by the manufacturer. The coverslips were mounted using VECTASHIELD HardSet Mounting Medium with DAPI (VWR) before proceeding with the imaging analysis. Data presented are the averages from two independent experiments containing two independent siRNA's each. The quantification of EdU positive cells were performed double blinded.
Cesium Chloride Density Gradient Centrifugation RPE cells were grown and transfected with two independent KDM5A siRNA for a total of 72 hr including BrdU treatment. Cells were labeled with BrdU for 12 hr and 30 min. For GFP-control and KDM4B stably expressing cells, the cells were harvested with BrdU labeling for 12 hr and 30min for a total of 48 hr. Cells were scraped and washed twice with cold PBS and the pellet was collected by centrifugation at 1000rpm for 5min. The cell pellet was resuspended and lysed in RIPA lysis buffer [50mM Tris pH 7.4, 150mM NaCl, 0.25% Sodium Deoxycholate, 1% NP40, 1mM EDTA, 10% Glycerol] supplemented with 100mg RNase A at 37 C for 2 hr. The sample was then vortexed after adding 10% SDS and 20 mg of proteinase K and sonicated for 10sec using microprobe at 3.5 setting on Branson Sonicator to reduce viscosity. The samples were incubated at 55 C for 2 hr followed by phenol:chloroform extraction of DNA three times. DNA was ethanol precipitated overnight. The precipitated DNA was resuspended in NEB CutSmart buffer supplemented with RNase A and digested with 200U of EcoRI (NEB) and BamHI (NEB) overnight at 37 C. Digested DNA was phenol:chloroform extracted and ethanol precipitated. Pellet was resuspended in 300mL TE and incubated at 37 C for 20 min to facilitate resuspension and concentration was measured with nanodrop. Meanwhile cesium chloride (1g/mL) was dissolved in TE until reaching a refractive index of 1.4024-1.4045. 150 mg of DNA was then mixed with cesium chloride and added to the heat sealable ultracentrifuge tube (Beckman #342413, 16x76mM). The gradient was then centrifuged for 66 hr in a VTi-65 vertical ultra rotor at 44,400 rpm at 25 C under vacuum. After centrifugation, an 18 g needle was used to make an outlet at the bottom of the tube and fractions were collected in a volume of 200-300 mL for a total of around 50 fractions. DNA concentration was measured for each fraction using nanodrop. The H:H fraction was then pooled together and diluted with 2.5 to 3 times TE volume. The pooled fractions were ethanol precipitated by the addition of glycogen (Roche). The precipitated DNA was resuspended in 100mL ddwater and incubated at 37 C for 20 min to dissolve the pellet. The rereplicated samples were analyzed by qPCR on a Roche LC480 using FastStart Universal SYBR Green Master Mix ROX (Roche) following the manufacturer's instructions at 5ng DNA per well including the input DNA. Fold change was determined after normalization of each sample to the corresponding input DNA. Data presented for KDM5A rereplication are the averages using two independent siRNAs. Data presented for KDM4B are the averages from six independent replicates. Genomic regions marked in Figures 4, 6 and 7 are based on GRCh37-hg19 genome assembly.
Chromatin Immunoprecipitation (ChIP) Sonication was performed with the Qsonica Q800R2 system (Qsonica). For KDM5A antibody ChIP, 0.3x10 6 RPE cells were seeded in 10cm plates and transfected with control or KDM5A siRNA in lipofectamine 3000 (Life Technology) following the supplier instructions. For KDM4A, KDM4B and histone mark assessment, RPE cells were arrested in 2mM HU for 20 hr prior to cross-linking. For DNA polymerase alpha assessment, RPE cells were arrested in 10mM Ro-3306 for 20 hr prior to cross-linking. Cells were cross-linked by adding 1% formaldehyde to the media for 13 min at 37 C and stopped with 0.125M glycine, pH2.6. Plates were washed with cold PBS, and all the cells were scraped off, centrifuged at 800 rpm for 5 min at 4 C. The pellet was resuspended in cellular lysis buffer (5mM PIPES pH8.00, 85mM KCl, 0.5% NP40) supplemented with protease and phosphatase inhibitors, incubated 5min on ice and centrifuged at 800 rpm, 5 min at 4 C. The pellet was resuspended in nuclear lysis buffer (NLB, 50mM Tris, pH 8.0, 10mM EDTA, 0.2% or 1.0% SDS). All histone ChIPs were carried out with chromatin made in NLB with 1.0% SDS and others in NLB containing 0.2% SDS. Chromatin was resuspended in NLB-1.0% SDS and were then sonicated at 70% amplitude 15 s on 45sec off setting for 35 min and NLB-0.2%SDS for 45 min. 4 mL of chromatin was reverse cross-linked overnight at 65 C in presence of proteinase K. After RNase treatment, DNA was isolated with phenol:chloroform extraction and checked on 1% agarose gel for a smear below 300bp. 1-10 mg of chromatin was precleared by centrifugation at 14,000rpm for 10min at 4 C. For each IP, chromatin was immunoprecipitated with 2mg of antibody in dilution IP buffer (16.7mM Tris pH 8.0, 1.2mM EDTA pH 8.0, 167mM NaCl, 0.2% SDS, 0.24% or 1.84% Triston-X-100) at 4 C overnight. Chromatin was precleared for 2 hr each with protein A agarose and magnetic protein A or protein G beads (Invitrogen; to match antibody isotype) before immunoprecipitation. The immunoprecipitated material was washed 2 times in dilution IP buffer, 1 time in TSE buffer (20mM Tris pH 8.0, 2mM EDTA pH8.0, 500mM NaCl, 1% Triton X-100, 0.1% SDS), 1 time in LiCl buffer (100mM Tris pH 8.0, 500mM LiCl, 1% deoxycholic acid, 1% NP40) and 2 times in TE (10mM Tris pH 8.0, 1mM EDTA pH8.0) before elution in elution buffer (50mM NaHCO3, 140mM NaCl, 1% SDS) with 10ug proteinase K at 1 hr 55 C 1000 rpm. The samples were removed from beads and reverse cross-linked at 65 C for 4 hr. Immunoprecipitated DNA was purified using either PCR purification columns (Promega) , ab9050) . For KDM5A ChIP, data presented are the averages from two independent siRNAs using two different KDM5A antibody. For Polymerase alpha and H3K4me3 ChIP's, data presented are the averages from six replicates. For KDM4A ChIP, data presented are the averages from eight replicates with two antibodies. For KDM4B ChIP, data presented are the averages from two independent cell lines. For H3K36me3 ChIP, data presented are the averages from four replicates. All the ChIPs were performed with at least two independent chromatin preparations from two independent siRNAs or two independently made RPE cell lines.
Cell Fractionation
Cytoplasmic, nuclear and chromatin fractions were prepared from RPE cells. Cell pellets were washed twice in ice cold PBS and resuspended in ice cold hypotonic buffer (10mM HEPES pH 7.9, 10mM KCl, 0.1M EDTA, 0.5M EGTA) and incubated on ice for 15 min. Swollen cells were lysed by addition of NP-40 to 10% with 10 s of vortexing. Lysed cells were centrifuged and the supernatant kept as cytoplasm. The nuclear pellet was resuspended in high salt buffer (10mM HEPES pH 7.9, 400mM NaCl, 1mM EDTA, 5mM EGTA) and incubated at 4 C for 15min with rotation. Extracts were centrifuged and the supernatant was kept as nuclear extract. The pellets were resuspended in N-Buffer (20mM Trish pH 7.5, 100mM KCl, 2mM MgCl2, 1mM CaCl2, 0.3M Sucrose, 0.1% Triton X-100, 3U per mL micrococcal nuclease). Samples were sonicated for 15 min at 70% amplitude in a Q700 cup horn (QSonica) and then incubated at room temperature for 15 min for MNase digestion. Reactions were stopped by addition of 5mM EDTA and centrifuged to clear. Supernatant was kept as chromatin extract.
HaloTag Mammalian Pulldown for Mass spectrometry HEK293T cells (12 3 10 6 cells) were transfected with the N-terminal HaloTag-KDM4B fusion (O94953) or the control HaloTag alone plasmid (Promega G6591) using FuGENE HD Transfection Reagent (Promega E2311). Twenty four hr post-transfection, cells were lysed in mammalian lysis buffer (50mM Tris-HCl, pH 7.5, 150mM NaCl, 1% Triton X-100, and 0.1% sodium deoxycholate) including protease Inhibitor cocktail and RQ1 RNase-Free DNase (Promega G6509) for 10min on ice. Using a syringe, lysates was homogenized and then further clarified by centrifugation at 14.000 x g for 5min. The resultant supernatants were incubated with HaloLink Resin (Promega G6509) that had been pre-equilibrated in TBS and 0.05% IGEPAL CA-640 (Sigma) for 15 min at 22 C with rotation. HaloTag pulldown complexes bound to resin were washed 5 times with wash buffer (Promega G6509), and protein interactors were eluted with SDS elution buffer (50mM Tris-HCl, pH 7.5, and 1% SDS). Eluted purified complexes were subjected to trypsin (Promega) gel digestion for 4 hr and then analyzed directly by nano LC/MS/MS with a NanoAcquity HPLC (Waters) interfaced with an Orbitrap Velos Pro (Thermo Scientific) tandem mass spectrometer by MS Bioworks, LLC (Ann Arbor, Michigan). A list of interactors is presented in Table S4 .
Immunoprecipitation
Immunoprecipitation was carried out as described previously in (Van Rechem et al., 2011; Van Rechem et al., 2015) . In brief, HU arrested HEK293T cells (2mM HU for 20 hr) were washed with cold PBS before being spun down. To obtain nuclei enriched extracts, the cell pellet was resuspended in cellular lysis buffer (5 mM PIPES pH8, 85 mM KCl, 0.5% NP40, protease and phosphatase inhibitors) and incubated 5 min on ice before being spun down. The pellet was lysed in IPH buffer (50mM Tris-HCl, pH 8.0, 150mM NaCl, 5mM EDTA, 0.5% NP-40 and 10% glycerol, protease and phosphatase inhibitors) and sonicated with a probe (Branson Sonifier 450) for 25sec. The lysate was then cleared by centrifugation at 4 C full speed for 10 min and quantified using Pierce BCA protein assay. For immunoprecipitation, 500ug of lysate was incubated overnight on a rotator at 4 C in 1mL of IPH buffer with 25mL of Dynabeads Protein A (Invitrogen 10002D), 2 mg of KDM4B antibody (ab191434, abcam) or rabbit IgG, and 100 mg/mL ethidium bromide. The beads were then washed five times in 1mL of IPH buffer with vortexing between each wash, resuspended in SDS sample loading buffer and heated at 95 C for 10min before being processed for western blot and probed for MCM2 (ab6153) and MCM5 (ab6154). Figure S1 . KDM5A Inhibition Promotes Site-Specific Copy Gains, Related to Figure 1 
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